Amgen and ONS:Edge invite you to attend a dinner program and discussion about the impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN). You'll learn about the correlation between CIN and infection, the possible consequences of FN, patients who are most at risk for FN, and the importance of conducting a comprehensive CIN risk assessment.
Register here.
This program has been planned and developed in collaboration with Amgen and ONS:Edge, Inc., a subsidiary of the Oncology Nursing Society, and is sponsored by Amgen.
This event qualifies for the ONS:Edge Unlock the Levels of Learning contest.
